Clinical Trial: To Study the Efficacy & Safety of Oral NA-921 (Bionetide) in Girls and Women with Rett Syndrome

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06849973) titled 'To Study the Efficacy & Safety of Oral NA-921 (Bionetide) in Girls and Women with Rett Syndrome' on Feb. 24.

Brief Summary: To study the efficacy & safety of oral Bionetide versus placebo in girls and women with Rett syndrome

Study Start Date: March 15, 2024

Study Type: INTERVENTIONAL

Condition: Rett Syndrome

Intervention: DRUG: Drug: Bionetide

NA-921 (Bionetide) solution administered based on the subject's weight at Baseline, twice daily for 12 weeks

DRUG: Placebo

NA-921 (Bionetide) placebo solution administered based on the subject's weight at Baseline, twice daily for 12 weeks

Recruitment Status: COMPLETED

Sponsor: Bio...